Predictors of Hepatitis B Surface Antigen Titers two decades after vaccination in a cohort of students and post-graduates of the Medical School at the University of Palermo, Italy
MG Verso 1  
N Lo Cascio 2,  
E Amodio 4,  
M Currieri 5,  
G Giammanco 6,  
D Ferraro 6,  
S De Grazia 6,  
More details
Hide details
Department of Sciences for Health Promotion and Mother-Child Care ‘G. D’Alessandro’, Occupational Health Section, University of Palermo, via del Vespro 143, 90127 Palermo, Italy
Health Workers Medical Service – University Hospital Policlinico ‘Paolo Giaccone’, via del Vespro 143, 90127 Palermo, Italy
Unit of Occupational Health – University Hospital Policlinico ‘Paolo Giaccone’, via del Vespro 143, 90127 Palermo, Italy Italy
Epidemiology and Programming Service – Department of Planning, Purchasing and Control ATS Brianza, Monza, Italy
School of Specialization in Occupational Health, School of Medicine, University of Palermo, Italy
Department of Sciences for Health Promotion and Mother-Child Care ‘G. D’Alessandro’, Microbiology Section, University of Palermo, via del Vespro 129, 90127 Palermo, Italy
Ann Agric Environ Med. 2017;24(2):303–306
Introduction and objective:
The introduction of a vaccine against hepatitis B virus (HBV) for newborn babies in Italy in 1991, extended to 12-year-old children for the first 12 years of application, has been a major achievement in terms of the prevention of HBV infection. The objective of this study was to analyse the long-term immunogenicity and effectiveness of HBV vaccination among healthcare students with different working seniorities.

Material and Methods:
A cross-sectional observational study of undergraduate and postgraduate students attending the Medical School of the University of Palermo was conducted from January 2014 – July 2016. HBV serum markers were performed with commercial chemiluminescence assays. Categorical variables were analyzed using the chi-square test (Mantel–Haenszel), whereas means were compared by using the Student’s t test. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were also calculated by a multivariable logistic regression, using a model constructed to examine predictors of anti-HBs titer above 10 mIU/mL, assumed as protective.

Of the 2,114 subjects evaluated – all vaccinated at infancy or at the age of 12 years and were HBsAg/anti-HBc negative – 806 (38.1%) had an anti-HBs titre <10 IU/L. The latter were younger, more likely to be attending a healthcare profession school (i.e., nursing and midwifery), than a medical postgraduate level school, and more likely to have been vaccinated in infancy (p <0.001, 95% CI 2.63–5.26, adjusted OR 3.70).

The results of the study suggest that assessment of HBV serum markers in workers potentially exposed to hospital infections is useful for identifying small numbers of unvaccinated subjects, or vaccinated subjects with low antibody titre, all of whom should be referred to a booster series of vaccinations.

MG Verso   
Department of Sciences for Health Promotion and Mother-Child Care ‘G. D’Alessandro’, Occupational Health Section, University of Palermo, via del Vespro 143, 90127 Palermo, Italy
1. World Health Organization: Media Centre. Hepatitis B. Available online at:
2. Tosti M.E. Istituto Superiore di Sanità – Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute (CNESPS): Principali risultati dei 30 anni di sorveglianza SEIEVA. Atti del XI Workshop SEIEVA. Il Sistema Epidemiologico Integrato dell’Epatite Virale Acuta (SEIEVA) a 30 anni dal suo avvio: riflessioni sullo stato dell’arte e prospettive future. Roma, 17 dicembre 2015. Available online at:
3. Piazza M, Da Villa G, Picciotto L, Abrescia N, Guadagnino V, Memoli AM, et al. Mass vaccination against hepatitis B in infants in Italy. Lancet. 1988; 332: 1132.
4. Zanetti AR, Tanzi E, Romanò L, Grappasonni I. Vaccination against hepatitis B: the Italian strategy. Vaccine. 1993; 11: 521–4.
5. Romanò L, Paladini S, Tagliacarne C, Zappa A, Zanetti AR. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination. Vaccine. 2009; 26: 3439–42.
6. Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, et al. Determination of immune memory to hepatitis B vaccination through early booster response in college students Hepatology. 2010; 51(5): 1547–54.
7. Hudu SA, Malik YA, Niazlin MT, Harmal NS, Adnan A, Alshrari AS, et al. Antibody and immune memory persistence post infant hepatitis B vaccination. Patient Prefer Adherence. 2013; 7: 981–6.
8. Noubiap JJ, Nansseu JR, Kengne KK, Tchokfe Ndoula S, Agyingi LA. Occupational exposure to blood, hepatitis B vaccine knowledge and uptake among medical students in Cameroon. BMC Med Educ. 2013; 13: 148.
9. Lohouès-Kouacou MJ, Assi C, Nigué L, Biékré AR, Ouattara A, Koné S, et al. Hepatitis B: cross-sectional study of knowledge and immunization among students at University of Cocody, Ivory Coast. Rev Epidemiol Sante Publique. 2013; 61(5): 494–8.
10. Riva MA, Madotto F, Conti S, Fornari C, Patronella G, Sormani M et al. Hepatitis B vaccination coverage and booster dose: results from a survey on healthcare students. G Ital Med Lav Ergon. 2012; 34 (3Suppl): 283–5.
11. Spradling PR, Williams RE, Xing J, Soyemi K, Towers J. Serologic testing for protection against hepatitis B virus infection among students at a health sciences university in the United States. Infect Control Hosp Epidemiol. 2012; 33(7): 732–6.
12. Carvalho P, Schinoni MI, Andrade J, Vasconcelos Rêgo MA, Marques P, et al. Hepatitis B virus prevalence and vaccination response in health care workers and students at the Federal University of Bahia, Brazil. Ann Hepatol. 2012; 11(3): 330–7.
13. Lasemi E, Haddadpour N, Navi F, Rakhshan A, Rakhshan V. Rate of acquired immunity in dental students after hepatitis B vaccination. Dent Res J (Isfahan). 2011; 8(3): 128–31.
14. Bruno A, Borella-Venturini M, Giraldo M, Mongillo M, Zanetti E, Beggio M, et al. Prevalence of virus hepatitis B markers among medical students. G Ital Med Lav Ergon. 2007; 29(3Suppl): 752–4.
15. Lin CS, Zhu JY, Mai L, Lee WH, Gao ZL. Status of vaccination against hepatitis B among postgraduate students in medical higher education institutions in Guangzhou. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007; 21(2): 114–6.
16. Techasathit W, Ratanasuwan W, Sonjai A, Sangsiriwut K, Anekthananon T, Suwanagool S. Vaccination against hepatitis B virus: are Thai medical students sufficiently protected? J Med Assoc Thai. 2005; 88(3): 329–34.
17. Lamberti M, De Rosa A, Garzillo EM, Corvino AR, Sannolo N, De Pascalis S, et al. Vaccination against hepatitis b virus: are Italian medical students sufficiently protected after the public vaccination programme? J Occup Med Toxicol. 2015; 10:41.
18. Coppola N, Corvino AR, De Pascalis S, Signoriello G, Di Fiore E, Nienhaus A, et al. The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy. BMC Infect Dis. 2015; 25: 15–149.
19. Saffar H, Saffar MJ, Ajami A, Khalilian AR, Shams-Esfandabad K, Mirabi AM. Long-term T-cell-mediated immunologic memory to hepatitis B vaccine in young adults following neonatal vaccination. Hepat Mon. 2014; 14(9): e22223.
20. Zanetti AR, Mariano A, Romanò L, D’amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005; 366: 1379–1384.
21. Italian Medicines Agency: Linee guida per la classificazione e conduzione degli studi osservazionali sui farmaci. Gazzetta Ufficiale 2008, 76. 31/03/ 2008. Available online at:
22. Colin W. Shepard, Edgar P. Simard, Lyn Finelli, Anthony E. Fiore, Beth P. Bell. Hepatitis B Virus Infection: Epidemiology and Vaccination. Epidemiologic Reviews; 2006, 28, 112–125.
23. Repubblica Italiana, Ministero della Salute: Circolare n. 19 del 30 novembre 2000 Protocollo per l’esecuzione della vaccinazione contro l’epatite virale B (D.M. 20 novembre 2000). Available online at:
24. Repubblica Italiana, Ministero della Salute: Piano Nazionale Prevenzione Vaccinale (PNPV) 2012–2014. Available online at:
25. Chiara F, Bartolucci GB, Mongillo M, Ferretto L, Nicolli A, Trevisan A. Hepatitis B vaccination at three months of age: a successful strategy? Vaccine. 2013; 31(13): 1696–1700.
26. Stroffolini T, Guadagnino V, Caroleo B, De Sarro G, Focà A, Liberto MC, et al. Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town. Infection. 2012; 40(3): 299–302.
27. CDC. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR 2013; 62(RR10): 1–19.
28. Avdicova M, Crasta PD, Hardt K, Kovac M: Lasting immune memory against hepatitis B following challenge 10–11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11–12 months of age. Vaccine. 2015; 33(23): 2727–33.
29. Publication WHO. Hepatitis B vaccines: WHO position paper–recommendations. Vaccine. 2010; 28: 589–590 Available online at: